AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,450 | -2.7% | 450 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $32,337 | +16.5% | 450 | 0.0% | 0.01% | +10.0% |
| Q1 2023 | $27,756 | +38.2% | 450 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $20,079 | +0.4% | 450 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $20,000 | +11.1% | 450 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $18,000 | -5.3% | 450 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $19,000 | +11.8% | 450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $17,000 | -64.6% | 450 | -69.0% | 0.01% | -66.7% |
| Q3 2021 | $48,000 | – | 1,450 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |